Efficacy of magnesium-amiodarone step-up scheme in critically ill patients with new-onset atrial fibrillation: A prospective observational study

Journal of Intensive Care Medicine

Volumn 23, Issue 1, 2008, Pages 61-66

  Sleeswijk, Mengalvio E ^a,b   Tulleken, Jaap E ^a   Van Noord, Trudeke ^a   Meertens, John H J M ^a   Ligtenberg, Jack J M ^a   Zijlstra, Jan G ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^b Intensive Care Unit Flevoziekenhuis Almere   (Netherlands)

Author keywords

Amiodarone; Atrial fibrillation; Critically ill patients; Intensive care unit; Magnesium sulphate

Indexed keywords

AMIODARONE; MAGNESIUM SULFATE;

ADULT; AGED; ARTICLE; BOLUS INJECTION; CLINICAL ARTICLE; COMBINATION CHEMOTHERAPY; CONTINUOUS INFUSION; CRITICAL ILLNESS; CRITICALLY ILL PATIENT; FEMALE; HEART ATRIUM FIBRILLATION; HEART RATE; HUMAN; LOADING DRUG DOSE; MALE; MONOTHERAPY; OBSERVATIONAL STUDY; PRIORITY JOURNAL; PROSPECTIVE STUDY; RELAPSE; SINUS RHYTHM;

AGED; AMIODARONE; ANTI-ARRHYTHMIA AGENTS; ATRIAL FIBRILLATION; CRITICAL ILLNESS; DRUG SYNERGISM; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; INTENSIVE CARE UNITS; MAGNESIUM SULFATE; MALE; PROSPECTIVE STUDIES;

EID: 38349057903     PISSN: 08850666     EISSN: 15251489     Source Type: Journal    
DOI: 10.1177/0885066607310181     Document Type: Article

References (20)

1. Brathwaite D., Weissman C. The new onset of atrial arrhythmias following major noncardiothoracic surgery is associated with increased mortality. Chest. 1998 ; 114: 462-468.
2. Kumar A. Intravenous amiodarone for therapy of atrial fibrillation and flutter in critically ill patients with severely depressed left ventricular function. South Med J. 1996 ; 89: 779-785.
3. Trappe HJ, Brandts B., Weismueller P. Arrhythmias in the intensive care patient. Curr Opin Crit Care. 2003 ; 9: 345-355.
4. Holt AW Hemodynamic responses to amiodarone in critically ill patients receiving catecholamine infusions. Crit Care Med. 1989 ; 17: 1270-1276.
5. Hughes M., Binning A. Intravenous amiodarone in intensive care. Time for a reappraisal? Intensive Care Med. 2000 ; 26: 1730-1739.
6. Bravo AE, Drewe J., Schlienger RG, Krahenbuhl S., Pargger H., Ummenhofer W. Hepatotoxicity during rapid intravenous loading with amiodarone: description of three cases and review of the literature. Crit Care Med. 2005 ; 33: 128-134.
7. Ashrafian H., Davey P. Is amiodarone an underrecognized cause of acute respiratory failure in the ICU? Chest. 2001 ; 120: 275-282.
8. Donaldson L., Grant IS, Naysmith MR, Thomas JS Acute amiodarone-induced lung toxicity. Intensive Care Med. 1998 ; 24: 626-630.
9. Gonzalez GA, Garcia Sanchez MV, la Mata GM, Mino FG. Early-onset acute toxic hepatitis induced by intravenous amiodarone administration. Gastroenterol Hepatol. 2002 ; 25: 392-394.
10. Skroubis T., Galiatsou E., Metafratzi Z., Karahaliou A., Kitsakos A., Nakos G. Amiodarone-induced acute lung toxicity in an ICU setting. Acta Anaesthesiol Scand. 2005 ; 49: 569-571.
11. Henyan NN, Gillespie EL, White CM, Kluger J., Coleman CI Impact of intravenous magnesium on postcardiothoracic surgery atrial fibrillation and length of hospital stay: a meta-analysis. Ann Thorac Surg. 2005 ; 80: 2402-2406.
12. Forlani S., De Paulis R., de Notaris S., et al. Combination of sotalol and magnesium prevents atrial fibrillation after coronary artery bypass grafting. Ann Thorac Surg. 2002 ; 74: 720-725.
13. Kalus JS, Spencer AP, Tsikouris JP, et al. Impact of prophylactic i.v. magnesium on the efficacy of ibutilide for conversion of atrial fibrillation or flutter. Am J Health Syst Pharm. 2003 ; 60: 2308-2312.
14. Moran JL, Gallagher J., Peake SL, Cunningham DN, Salagaras M., Leppard P. Parenteral magnesium sulfate versus amiodarone in the therapy of atrial tachyarrhythmias: a prospective, randomized study. Crit Care Med. 1995 ; 23: 1816-1824.
15. Balser JR Beta-adrenergic blockade accelerates conversion of postoperative supraventricular tachyarrhythmias. Anesthesiology. 1998 ; 89: 1052-1059.
16. Davey MJ, Teubner D. A randomized controlled trial of magnesium sulfate, in addition to usual care, for rate control in atrial fibrillation. Ann Emerg Med. 2005 ; 45: 347-353.
17. Mayr AJ, Dunser MW, Ritsch N., et al. High-dosage continuous amiodarone therapy to treat new-onset supraventricular tachyarrhythmias in surgical intensive care patients: an observational study. Wien Klin Wochenschr. 2004 ; 116: 310-317.
18. Cybulski J., Budaj A., Danielewicz H., Maciejewicz J., Ceremuzynski L. A new-onset atrial fibrillation: the incidence of potassium and magnesium deficiency: the efficacy of intravenous potassium/magnesium supplementation in cardioversion to sinus rhythm. Kardiol Pol. 2004 ; 60: 578-581.
19. Piotrowski AA, Kalus JS Magnesium for the treatment and prevention of atrial tachyarrhythmias. Pharmacotherapy. 2004 ; 24: 879-895.
20. Reinelt P., Karth GD, Geppert A., Heinz G. Incidence and type of cardiac arrhythmias in critically ill patients: a single center experience in a medical-cardiological ICU. Intensive Care Med. 2001 ; 27: 1466-1473.